Navigation Links
PharmAthene to Present at the BIO CEO & Investor Conference 2008
Date:2/6/2008

ANNAPOLIS, Md., Feb. 6 /PRNewswire-FirstCall/ -- PharmAthene, Inc., (Amex: PIP) a biodefense company developing medical countermeasures against biological and chemical threats, announced today that David P. Wright, President and Chief Executive Officer of PharmAthene, will present at the BIO CEO & Investor Conference 2008, in New York, NY on Wednesday, February 13, 2008 at 2:00 p.m. The presentation is scheduled to take place in the Basildon Room at the Waldorf Astoria Hotel.

PharmAthene's presentation will be available via webcast on the company's website at http://www.pharmathene.com. A link to access the webcast will be accessible from both the homepage and the investor relations pages of the PharmAthene corporate website. For assistance, contact Stacey Jurchison at 410-269-2610.

About PharmAthene, Inc.

PharmAthene (Amex: PIP) was formed to meet the critical needs of the United States and its allies by developing and commercializing medical countermeasures against biological and chemical weapons. PharmAthene's lead programs include Valortim(TM) for the prevention and treatment of anthrax infection and Protexia(R) for the prevention and treatment of morbidity and mortality associated with exposure to chemical nerve agents. For more information on PharmAthene, please visit http://www.pharmathene.com.


'/>"/>
SOURCE PharmAthene Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Hearing Scheduled in the Delaware Court of Chancery for August 27, 2007 to Establish the Valid Approval and Consummation of the Merger Between PharmAthene, Inc. and Healthcare Acquisition Corp.
2. Proceedings to Affirm Merger Between PharmAthene and Healthcare Acquisition Corp Initiated in Delaware Chancery Court
3. PharmAthene Named as Contractor in $13.9 Million Award Notice Published by the Department of Health and Human Services
4. Delaware Court Denies Motion by SIGA Technologies Seeking to Dismiss PharmAthenes Legal Action in Breach of Contract Lawsuit Against SIGA
5. Imagenetix Inc. to Present at Noble Small Cap Financial Conference on August 21, 2007
6. Avicena Group to Present at Noble Financial Conference
7. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
8. Strategic Diagnostics to Present at Two Upcoming Investor Conferences
9. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
10. CEL-SCI to Present at the Noble Financial Conference
11. Lexicon Presents Class of Compounds Modulating TPH1, the Target for its LX1031 Investigational Drug for Irritable Bowel Syndrome
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/24/2020)... MONTEREY, Calif. (PRWEB) , ... January 24, 2020 ... ... the launch of their RedySmart™ mass flow meters and controllers ideal ... as an ideal upgrade to antiquated rotameters. These thermal instruments employ high-precision ...
(Date:1/22/2020)... ... ... QCDx , a private biotech company that has developed a breakthrough Circulating ... of the proprietary RareScope™ instrument to the Carole and Ray Neag Comprehensive Cancer Center ... “The RareScope can detect and isolate intact and live Circulating Tumor Cells from a ...
(Date:1/8/2020)... Conn. (PRWEB) , ... January 08, 2020 , ... ... whose exceptional quality and care helps couples and individuals grow their family, has ... prestigious Top Doc award by Castle Connolly. Since 1991, the renowned publishing company ...
(Date:1/7/2020)... ... January 06, 2020 , ... ABCT , ... biosciences ventures invited to participate in the annual program. Twelve ventures will participate ... and a professional network. All startups will receive an entrepreneur coach, access to ...
Breaking Biology Technology:
(Date:2/6/2020)... ... February 06, 2020 , ... ... specializing in complex interventional medical device and pharmaceutical trials, announced that Ms. ... this newly established role, Dorothy oversees the development and execution of regulatory ...
(Date:1/30/2020)... ... January 30, 2020 , ... Accelera Canada , a full-service ... Canadian market, is pleased to announce that the company has opened the doors of ... launched in 2017. , “We are so thrilled to now have all our ...
(Date:1/28/2020)... ... January 28, 2020 , ... ... improve care efficiency, reduce total cost of care, and limit the utilization of ... healthcare provider group headquartered in San Antonio, Texas specializes in improving care delivery ...
Breaking Biology News(10 mins):